DarioHealth Corp.
DRIO | NASDAQ
$7.07
-$0.13 (-1.81%)
At close: Sep 21, 2026, 4:00 PM ET
$6.95
-$0.12 (-1.70%)
After-hours:
Sep 21, 2026, 4:27 PM ET
-1.81%
(1D)Rating
Updated: Sep 1, 2026Key Statistics
Market Data
Market Cap $51.69M
1D Range
6.95 7.13
52W Range
5.85 17.74
Valuation (TTM)
PE 10.25
PB 0.94
EV/EBITDA -2.35
Valuation (NTM)
Forward PE N/A
Forward PEG -0.28
Price Target $12.50
Cash Flow
FCF Yield -48.1%
SBC Adj. FCF Yield -56.1%
SBC Impact -16.5%
Margins
Gross Margin 56.1%
Operating Margin -328.8%
FCF Margin -118.5%
Growth (CAGR)
Revenue 3Y | 5Y -7.6% |
10.1%
Dil EPS 3Y | 5Y 185.1% |
69.4%
FCF 3Y | 5Y 25.9% |
19.4%
Returns
ROA 70.2%
ROE 104.2%
ROIC -78.4%
Financial Health
Net Debt
$17.38M
Current Ratio 2.31
Interest Coverage -12.35
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health soluti...
Sector Healthcare
Industry Medical - Specialties
Employees 163
IPO Date Mar 13, 2016
Website www.dariohealth.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$14
Upside
+98.02%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove DRIO